NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹2.19 Cr | ₹1.37 Cr | ₹1.91 Cr | ₹2.38 Cr | ₹0.99 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹2.19 Cr |
Mar2023 | ₹1.37 Cr |
Mar2022 | ₹1.91 Cr |
Mar2021 | ₹2.38 Cr |
Mar2020 | ₹0.99 Cr |
How is Deferred Tax Assets / Liabilities of NGL FINECHEM Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2.19 Cr | 60.15 | |
Mar2023 | ₹1.37 Cr | -28.20 | |
Mar2022 | ₹1.91 Cr | -19.76 | |
Mar2021 | ₹2.38 Cr | 140.69 | |
Mar2020 | ₹0.99 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹699.3 Cr | 1.6% | 1.9% | -53.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 1.6% |
1.9% |
-53.4% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses